Krsnaa Diagnostics surged 5% after SEBI-registered FrontWave Research projected 30%+ long-term upside, citing PPP leadership and retail growth. Its Rajasthan mega project could add ₹300-₹350 crore annually from FY27. Retail touchpoints have scaled 7-fold to 2,400+, targeting 20% revenue share by FY27. Q1FY26 profit rose 15% to ₹205 crore, margins at 27%.